Inventor profile of:

Georg Winter

City:

Vienna

Country:

Austria

Published Applications:

16

Last publication date:

2024-04-25

Top Assignees for applications by Georg Winter

The entities that hold a legal rights for patent applications filed by inventor Winter Georg:

Recent patent applications by Winter Georg

Georg Winter from Vienna, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-04-25
US20240132485A1
Chemistry; metallurgy

HETEROCYCLIC CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF

#2 | 2023-04-27
US20230131952A1
Chemistry; metallurgy

DEGRADATION OF PROTEIN KINASES BY CONJUGATION OF PROTEIN KINASE INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE

#3 | 2023-04-20
US20230124700A1
Chemistry; metallurgy

OXAZOLE AND THIOAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF

#4 | 2022-05-05
US20220135967A1
Chemistry; metallurgy

TUNABLE ENDOGENOUS PROTEIN DEGRADATION

#5 | 2021-09-30
US20210301286A1
Chemistry; metallurgy

TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES

#6 | 2021-03-04
US20210061811A1
Chemistry; metallurgy

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

#7 | 2021-01-21
US20210015929A1
Human necessities

Methods to induce targeted protein degradation through bifunctional molecules

#8 | 2020-10-08
US20200317635A1
Chemistry; metallurgy

Methods to induce targeted protein degradation through bifunctional molecules

#9 | 2019-12-12
US20190374657A1
Human necessities

Tunable endogenous protein degradation with heterobifunctional compounds

#10 | 2019-12-12
US20190374528A1
Human necessities

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

#11 | 2019-12-05
US20190365875A1
Human necessities

Regulating chimeric antigen receptors

#12 | 2019-08-29
US20190263823A1
Chemistry; metallurgy

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

#13 | 2019-05-23
US20190151457A1
Human necessities

Methods to induce targeted protein degradation through bifunctional molecules

#14 | 2019-03-07
US20190071415A1
Chemistry; metallurgy

Methods to induce targeted protein degradation through bifunctional molecules

#15 | 2018-06-28
US20180179522A1
Chemistry; metallurgy

Tunable endogenous protein degradation

#16 | 2018-06-21
US20180169109A1
Human necessities

Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses

InventorID:

2218112 ⎘